ORCID as entered in ROS

Select Publications
2019, 'Recently alloactivated CD4(+)CD8(-)CD25(+)T regulatory cells express CD8alpha and are potent suppressor cells', in JOURNAL OF IMMUNOLOGY, AMER ASSOC IMMUNOLOGISTS, CA, San Diego, Vol. 202, presented at 103rd Annual Meeting of the American-Association-of-Immunologists, CA, San Diego, 09 May 2019 - 13 May 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000524982500109&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2019, 'Activation of naive CD4+CD25+FOXP3+Treg by specific autoantigen and Th2 cytokines IL-4 and IL-5 induces autoantigen specific Treg that inhibit EAE', in The Journal of Immunology, Oxford University Press (OUP), Vol. 202, pp. 116.16 - 116.16, http://dx.doi.org/10.4049/jimmunol.202.supp.116.16
,2019, 'Recently alloactivated CD4+CD8−CD25+T regulatory cells express CD8alpha and are potent suppressor cells', in The Journal of Immunology, Oxford University Press (OUP), Vol. 202, pp. 57.20 - 57.20, http://dx.doi.org/10.4049/jimmunol.202.supp.57.20
,2019, 'Th2 cytokines and specific donor alloantigen activated CD4+CD25+T cells reverse chronic rejection: role of IL-4 and IL-5 in promoting antigen-specific Treg', in The Journal of Immunology, Oxford University Press (OUP), Vol. 202, pp. 186.11 - 186.11, http://dx.doi.org/10.4049/jimmunol.202.supp.186.11
,2019, 'Non-Contrast Computed Tomography Based Patient Selection Achieves Similar Outcomes to Advanced Neuroimaging in Late Time Window Endovascular Thrombectomy', in STROKE, LIPPINCOTT WILLIAMS & WILKINS, HI, Honolulu, Vol. 50, presented at American-Heart-Association/American-Stroke-Association International Stroke Conference / State-of-the-Science Stroke Nursing Symposium, HI, Honolulu, 06 February 2019 - 08 February 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000478733400150&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2018, 'Factors associated with delayed hospital presentation for acute stroke events in South Western Sydney', in INTERNATIONAL JOURNAL OF STROKE, SAGE PUBLICATIONS LTD, Vol. 13, pp. 24 - 24, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000440952200111&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2018, 'Alloactivation of Human CD4+CD25+CD127loCD45RA-Fox3hi Treg Population to Induce Potential Alloantigen Specific Treg', in TRANSPLANTATION, LIPPINCOTT WILLIAMS & WILKINS, SPAIN, Madrid, Vol. 102, pp. S145 - S145, presented at 27th International Congress of the Transplantation-Society (TTS), SPAIN, Madrid, 30 June 2018 - 05 July 2018, http://dx.doi.org/10.1097/01.tp.0000542769.25232.5b
,2018, 'Activation of Human Naive T Regulatory Cells for MS Therapy By Stimulation with Antigen and Interleukin-4', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, CA, San Diego, Vol. 24, pp. 89 - 89, presented at ACTRIMS Forum, CA, San Diego, 01 February 2018 - 03 February 2018, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000429034600198&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2018, 'Phenotypic Analysis of T Regulatory Cells in Multiple Sclerosis Patients', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, CA, San Diego, Vol. 24, pp. 93 - 94, presented at ACTRIMS Forum, CA, San Diego, 01 February 2018 - 03 February 2018, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000429034600207&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2018, 'Response to Immunosuppressive Therapy in Cerebral Amyloid Angiopathy-related Inflammation', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, AUSTRALIA, Sydney, Vol. 25, pp. 492 - 492, presented at Congress of the Pan-Asian-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (PACTRIMS), AUSTRALIA, Sydney, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000460691800161&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2017, 'CD8 Expression Increases Suppressive Ability of CD4+CD25+Treg and is a Marker of Antigen-Specificity', in TRANSPLANTATION, LIPPINCOTT WILLIAMS & WILKINS, CANADA, Victoria, Vol. 101, pp. S37 - S37, presented at 15th Transplantation Science Symposium (TSS) of the Transplantation-Society, CANADA, Victoria, 24 May 2017 - 26 May 2017, http://dx.doi.org/10.1097/01.tp.0000520351.47820.c8
,2017, 'Human CD4+CD25+CD127loFOXP3+Treg Activation by IL-4 and Alloantigen Induces Activated Treg that do not Express CD45RA and Express the IL-5 Receptor Alpha (CD125)', in TRANSPLANTATION, LIPPINCOTT WILLIAMS & WILKINS, CANADA, Victoria, Vol. 101, pp. S7 - S7, presented at 15th Transplantation Science Symposium (TSS) of the Transplantation-Society, CANADA, Victoria, 24 May 2017 - 26 May 2017, http://dx.doi.org/10.1097/01.tp.0000520300.20897.2c
,2017, 'Interleukin 5 (IL-5) Treatment Prevents Chronic Allograft Rejection by Promoting IL-5 Receptor Expressing CD4+CD25+T Regulatory Ts2 Cells', in TRANSPLANTATION, LIPPINCOTT WILLIAMS & WILKINS, CANADA, Victoria, Vol. 101, pp. S43 - S43, presented at 15th Transplantation Science Symposium (TSS) of the Transplantation-Society, CANADA, Victoria, 24 May 2017 - 26 May 2017, http://dx.doi.org/10.1097/01.tp.0000520363.08810.76
,2017, 'TIMING OF HIGH-EFFICACY DISEASE MODIFYING THERAPIES FOR RELAPSING-REMITTING MULTIPLE SCLEROSIS', in JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, BMJ PUBLISHING GROUP, AUSTRALIA, Gold Coast, Vol. 88, presented at Annual Scientific Meeting of the Australian-and-New-Zealand-Association-of-Neurologists (ANZAN), AUSTRALIA, Gold Coast, 09 May 2017 - 12 May 2017, http://dx.doi.org/10.1136/jnnp-2017-316074.16
,2017, 'Contribution of different relapse phenotypes to disability in multiple sclerosis', in Multiple Sclerosis, Vol. 23, pp. 266 - 276, http://dx.doi.org/10.1177/1352458516643392
,2016, 'Comparison of 5-year treatment outcomes between alemtuzumab versus natalizumab, fingolimod and interferon β-1a', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, ENGLAND, London, Vol. 22, pp. 829 - 832, presented at 32nd Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), ENGLAND, London, 14 September 2016 - 17 September 2016
,2016, 'MSFIRST - utilising a longitudinal, prospective, comparative drug safety module for use in everyday MS clinical practice to evaluate and track incidence and characteristics of safety outcomes in MS patients on therapy over the long term', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, ENGLAND, London, Vol. 22, pp. 342 - 343, presented at 32nd Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), ENGLAND, London, 14 September 2016 - 17 September 2016
,2016, 'Pregnancy protects against long-term disability accrual in relapsing-remitting MS', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, ENGLAND, London, Vol. 22, pp. 120 - 122, presented at 32nd Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), ENGLAND, London, 14 September 2016 - 17 September 2016
,2016, 'Australian cladribine experience', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, ENGLAND, London, Vol. 22, pp. 289 - 290, presented at 32nd Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), ENGLAND, London, 14 September 2016 - 17 September 2016, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000383267201360&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2016, 'Individual response to disease modifying therapies: a global observational cohort study', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, ENGLAND, London, Vol. 22, pp. 358 - 360, presented at 32nd Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), ENGLAND, London, 14 September 2016 - 17 September 2016, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000383267201468&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2016, 'Activation of Human CD4+CD25+CD127loFOXP3+Treg by IL-4 and alloantigen induces activated Treg that do not express CD45RA and express the IL-5 receptor alpha (CD125)', in TRANSPLANTATION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 100, pp. S460 - S460, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000436953201100&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2016, 'Interleukin-5 therapy prevents chronic allograft rejection by induction of antigen specific CD4+CD25+T regulatory cells', in TRANSPLANTATION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 100, pp. S65 - S65, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000436953200108&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2016, 'Recently alloactivated CD4+CD8-CD25+Treg express CD8 and are the antigen-specific Treg', in TRANSPLANTATION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 100, pp. S120 - S120, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000436953200190&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2016, 'In Vitro Reactivity of CD4(+) T Cells Subsets from Hosts with Antigen Specific Transplant Tolerance Mediated by CD4(+)CD25(+) T Cells', in AMERICAN JOURNAL OF TRANSPLANTATION, WILEY-BLACKWELL, MA, Boston, Vol. 16, pp. 512 - 512, presented at American Transplant Congress, MA, Boston, 11 June 2016 - 15 June 2016, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000383373903337&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2015, 'Efficacy and Safety of Natalizumab in Multiple Sclerosis: Interim Observational Program Results from an Australian Cohort.', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, SOUTH KOREA, Seoul, Vol. 22, pp. 419 - 420, presented at 8th Congress of the Pan-Asian-Committee-for-Research-and-Treatment-of-Multiple-Sclerosis (PACTRIMS), SOUTH KOREA, Seoul, 19 November 2015 - 21 November 2015, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000372242400088&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2015, 'Interleukin-5 therapy prevents chronic allograft rejection by introduction of T regulatory cells.', in Transplantation, Lippincott, Williams & Wilkins, Lorne, AUSTRALIA, Vol. 99, pp. S4 - S4, presented at 14th Transplantation Science Symposium of the Transplantation-Society (TSS), Lorne, AUSTRALIA, 11 November 2015 - 13 November 2015
,2015, 'Recently alloactivated CD4+CD8-CD25+TREG express CD8 and are the antigen-specific TREG', in Transplantation, Lippincott, Williams & Wilkins, Lorne, AUSTRALIA, Vol. 99, pp. S34 - S34, presented at 14th Transplantation Science Symposium of the Transplantation-Society (TSS), Lorne, AUSTRALIA, 11 November 2015 - 13 November 2015
,2015, 'First-line injectable therapy and pregnancy protect against long-term disability accrual in patients with relapse-onset multiple sclerosis', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, AUSTRALIA, Melbourne, Vol. 21, pp. NP15 - NP15, presented at MS Research Australia Progress in MS Research Conference, AUSTRALIA, Melbourne, 29 October 2015 - 30 October 2015, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000365611900037&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2015, 'Immunomodulatory therapy slows accumulation of disability in moderately advanced multiple sclerosis', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, AUSTRALIA, Melbourne, Vol. 21, pp. NP14 - NP14, presented at MS Research Australia Progress in MS Research Conference, AUSTRALIA, Melbourne, 29 October 2015 - 30 October 2015, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000365611900036&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2015, '10-year progression predictors after first treatment initiation in a relapsing-remitting MS cohort', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, SPAIN, Barcelona, Vol. 21, pp. 100 - 102, presented at 31st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), SPAIN, Barcelona, 07 October 2015 - 10 October 2015, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000365729400172&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2015, 'Effect of relapse phenotype on the accumulation of disability in relapsing-remitting multiple sclerosis', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, SPAIN, Barcelona, Vol. 21, pp. 726 - 728, presented at 31st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), SPAIN, Barcelona, 07 October 2015 - 10 October 2015, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000365729402256&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2015, 'Immunomodulatory therapy slows accumulation of disability in moderately advanced multiple sclerosis', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, SPAIN, Barcelona, Vol. 21, pp. 308 - 310, presented at 31st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), SPAIN, Barcelona, 07 October 2015 - 10 October 2015, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000365729401014&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2015, 'Interleukin 5 mediates disease protection associated with parasite infestation in EAE', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, SPAIN, Barcelona, Vol. 21, pp. 430 - 430, presented at 31st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), SPAIN, Barcelona, 07 October 2015 - 10 October 2015
,2015, 'MS FIRST - utilising a drug safety module for use in MS clinical practice to evaluate lymphocyte reduction in fingolimod treatment over time, demographic predictors of lymphopenia and association with reported safety events', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, SPAIN, Barcelona, Vol. 21, pp. 18 - 19, presented at 31st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), SPAIN, Barcelona, 07 October 2015 - 10 October 2015, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000365729400025&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2015, 'Natural CD4(+)CD25(+)T regulatory cells (nTreg) cultured with antigen and Th2 cytokines, suppress induction of EAE', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, SPAIN, Barcelona, Vol. 21, pp. 537 - 537, presented at 31st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), SPAIN, Barcelona, 07 October 2015 - 10 October 2015, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000365729401427&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2015, 'Risk of early relapse following switch to oral agents for multiple sclerosis', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, SPAIN, Barcelona, Vol. 21, pp. 270 - 271, presented at 31st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), SPAIN, Barcelona, 07 October 2015 - 10 October 2015, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000365729400466&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2015, 'A novel small molecule neurotrophin-based strategy for treating demyelinating diseases', in JOURNAL OF NEUROCHEMISTRY, WILEY-BLACKWELL, AUSTRALIA, Cairns, Vol. 134, pp. 285 - 285, presented at 25th Biennial Meeting of the International-Society-for-Neurochemistry Jointly with the 13th Meeting of the Asian-Pacific-Society-for-Neurochemistry in Conjunction with the 35th Meeting of the Australasian-Neuroscience-Society, AUSTRALIA, Cairns, 23 August 2015 - 27 August 2015, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000360206300717&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2015, 'INDUCTION OF POTENT ANTIGEN SPECIFIC TREG CELLS FROM NAIVE TTREG BY ALLOANTIGEN AND TH2 CYTOKINES', in IMMUNOLOGY AND CELL BIOLOGY, NATURE PUBLISHING GROUP, AUSTRALIA, ANU Campus, Canberra, Vol. 93, pp. A31 - A31, presented at 33rd Annual Scientific Meeting of the Transplantation-Society-of-Australia-and-New Zealand, AUSTRALIA, ANU Campus, Canberra, 21 June 2015 - 23 June 2015, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000363320100078&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2015, 'INTERLEUKIN-5 THERAPY PREVENTS CHRONIC ALLOGRAFT REJECTION BY INDUCTION OF T REGULATORY CELLS', in IMMUNOLOGY AND CELL BIOLOGY, NATURE PUBLISHING GROUP, AUSTRALIA, ANU Campus, Canberra, Vol. 93, pp. A31 - A31, presented at 33rd Annual Scientific Meeting of the Transplantation-Society-of-Australia-and-New Zealand, AUSTRALIA, ANU Campus, Canberra, 21 June 2015 - 23 June 2015, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000363320100077&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2015, 'RECENTLY ALLOACTIVATED CD4+CD8-CD25+TREG EXPRESS CD8 AND ARE THE ANTIGEN SPECIFIC TREG', in IMMUNOLOGY AND CELL BIOLOGY, NATURE PUBLISHING GROUP, AUSTRALIA, ANU Campus, Canberra, Vol. 93, pp. A29 - A29, presented at 33rd Annual Scientific Meeting of the Transplantation-Society-of-Australia-and-New Zealand, AUSTRALIA, ANU Campus, Canberra, 21 June 2015 - 23 June 2015, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000363320100073&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2014, 'Evaluation of common criteria of progression of disability in a large observational cohort', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, MA, Boston, Vol. 20, pp. 62 - 63, presented at Joint ACTRIMS-ECTRIMS Meeting, MA, Boston, 10 September 2014 - 13 September 2014
,2014, 'Comparative efficacy of switch to natalizumab or fingolimod in active relapsing-remitting multiple sclerosis', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, MA, Boston, Vol. 20, pp. 195 - 196, presented at Joint ACTRIMS-ECTRIMS Meeting, MA, Boston, 10 September 2014 - 13 September 2014, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000354441300452&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2014, 'Comparison of fingolimod versus interferon beta/glatiramer acetate as second-line therapy in active multiple sclerosis', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, MA, Boston, Vol. 20, pp. 193 - 193, presented at Joint ACTRIMS-ECTRIMS Meeting, MA, Boston, 10 September 2014 - 13 September 2014, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000354441300448&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2014, 'Interleukin-12 Promotes Induction of Potent Th1-Like CD4(+)CD25(+)T Regulatory Cells That Inhibit Allograft Rejection in Unmodified Hosts.', in TRANSPLANTATION, LIPPINCOTT WILLIAMS & WILKINS, CA, San Francisco, Vol. 98, pp. 24 - 24, presented at World Transplant Congress, CA, San Francisco, 26 July 2014 - 31 July 2014, http://dx.doi.org/10.1097/00007890-201407151-00070
,2014, 'Interleukin-5 Therapy Prevents Chronic Allograft Rejection By Induction of T Regulatory Cells', in TRANSPLANTATION, LIPPINCOTT WILLIAMS & WILKINS, CA, San Francisco, Vol. 98, pp. 403 - 403, presented at World Transplant Congress, CA, San Francisco, 26 July 2014 - 31 July 2014, http://dx.doi.org/10.1097/00007890-201407151-01329
,2014, 'The Test for Tolerance - Diagnosing Transplant Tolerance By In Vitro Assay of CD4(+)CD25(+)T Cells', in TRANSPLANTATION, LIPPINCOTT WILLIAMS & WILKINS, CA, San Francisco, Vol. 98, pp. 401 - 401, presented at World Transplant Congress, CA, San Francisco, 26 July 2014 - 31 July 2014, http://dx.doi.org/10.1097/00007890-201407151-01323
,2014, 'Interleukin-5 Therapy Prevents Chronic Allograft Rejection By Induction of T Regulatory Cells', in AMERICAN JOURNAL OF TRANSPLANTATION, WILEY-BLACKWELL, CA, San Francisco, Vol. 14, pp. 403 - 403, presented at World Transplant Congress, CA, San Francisco, 26 July 2014 - 31 July 2014, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000338033301678&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2014, 'The Test for Tolerance - Diagnosing Transplant Tolerance By In Vitro Assay of CD4(+)CD25(+)T Cells', in AMERICAN JOURNAL OF TRANSPLANTATION, WILEY-BLACKWELL, CA, San Francisco, Vol. 14, pp. 401 - 401, presented at World Transplant Congress, CA, San Francisco, 26 July 2014 - 31 July 2014, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000338033301672&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2014, 'INTERLEUKIN-12 PROMOTES INDUCTION OF POTENT TH1-LIKE CD4(+)CD25(+)T REGULATORY CELLS THAT INHIBIT ALLOGRAFT REJECTION IN UNMODIFIED HOSTS', in IMMUNOLOGY AND CELL BIOLOGY, NATURE PUBLISHING GROUP, AUSTRALIA, ANU Campus, Canberra, Vol. 92, pp. A24 - A24, presented at 32nd Annual Scientific Meeting of the Transplantation-Society-of-Australia-and-New-Zealand, AUSTRALIA, ANU Campus, Canberra, 10 June 2014 - 13 June 2014, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000342376300058&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2014, 'Interleukin-5 Therapy Prevents Chronic Allograft Rejection By Induction of T Regulatory Cells', in IMMUNOLOGY AND CELL BIOLOGY, NATURE PUBLISHING GROUP, ANU Campus, Canberra, AUSTRALIA, Vol. 92, pp. A25 - A25, presented at 32nd Annual Scientific Meeting of the Transplantation-Society-of-Australia-and-New-Zealand, ANU Campus, Canberra, AUSTRALIA, 10 June 2014 - 13 June 2014, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000342376300061&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,